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ABSTRACT
A common mechanism for inducibly controlling pro-
tein function relies on reconstitution of split protein
fragments using chemical or light-induced dimeriza-
tion domains. A protein is split into fragments that
are inactive on their own, but can be reconstituted
after dimerization. As many split proteins retain affin-
ity for their complementary half, maintaining low ac-
tivity in the absence of an inducer remains a chal-
lenge. Here, we systematically explore methods to
achieve tight regulation of inducible proteins that
are effective despite variation in protein expression
level. We characterize a previously developed split
Cre recombinase (PA-Cre2.0) that is reconstituted
upon light-induced CRY2-CIB1 dimerization, in cul-
tured cells and in vivo in rodent brain. In culture,
PA-Cre2.0 shows low background and high induced
activity over a wide range of expression levels, while
in vivo the system also shows low background and
sensitive response to brief light inputs. The consis-
tent activity stems from fragment compartmentaliza-
tion that shifts localization toward the cytosol. Ex-
tending this work, we exploit nuclear compartmental-
ization to generate light-and-chemical regulated ver-
sions of Cre recombinase. This work demonstrates
in vivo functionality of PA-Cre2.0, describes new ap-
proaches to achieve tight inducible control of Cre
DNA recombinase, and provides general guidelines
for further engineering and application of split pro-
tein fragments.
INTRODUCTION
Since the first understanding that split fragments of a pro-
tein could complement each other, allowing restoration of
biological activity (1–3), methods utilizing complementa-
tion or reconstitution of split protein fragments have been
widely used for sensor and protein control applications. Al-
though some split protein fragments have sufficient affin-
ity to assemble on their own, protein fragments that do not
self-assemble can be fused to proteins that interact, allowing
conditional reconstitution of activity due to the increased
proximity (4,5).
When utilized in live cells, split proteins have most com-
monly been used as reporters to detect interacting proteins.
Some of the earliest split protein sensors were transcription
factors withmodularDNAbinding and activation domains
that could be split and functionally reconstituted through
a protein–protein interaction (6). Another early-developed
split protein sensorwas ubiquitin, whichwhen reconstituted
can allow binding of a ubiquitin protease and coincident
cleavage of a reporter (4). Subsequently, split forms of many
other reporter proteins have been developed, including split
DHFR, GFP and other fluorescent proteins, Cre recombi-
nase, beta-lactamase and luciferase (5,7–9).
While split proteins have been most widely adopted for
use as reporters of protein interaction, similar designs can
also be used to control protein activity using light or a chem-
ical switch to induce proximity. In this scenario, each half of
a split enzyme or other protein is attached to one partner of
a protein pair that conditionally dimerizes. Chemically in-
duced dimerization systems, in which domains are brought
together by a chemical ligand (10), have been applied to a
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range of protein targets.More recently, light induced dimer-
ization systems have also been developed that accomplish
similar functions, but with the benefits of spatial regulation
and reversibility (11,12). Such split protein approaches have
been used to conditionally control activity of proteins such
as Cre recombinase (13–15), transcriptional activators (16–
19), and proteases (20–22). In a recent study, a computa-
tional scoring approach to facilitate design of ideal protein
split sites was developed and used to conditionally control
activity of several split signaling proteins (23).
Two main strategies have been used to regulate biolog-
ical function with split proteins. A protein with indepen-
dent separable domains can be split between these domains,
as in the case of a transcription factor DNA binding do-
main and activation domain (6). In this case, the modular
domains do not interact and are functionally independent,
and the dimerization simply serves to tether the activation
domain in proximity to the DNA binding element. In many
other cases, however, a protein does not have independent
domains. Splitting such proteins yields fragments that may
retain substantial affinity even under non-inducing condi-
tions. Affinity of these fragments is required to reconstitute
protein function, but can contribute to background activ-
ity. A key parameter for tight inducible control of these pro-
teins is the concentration of the protein fragments in the cell:
self-assembly under non-induced conditions is more likely
to occur as the protein concentration of the fragments in-
creases. To circumvent this issue, several different strategies
have been taken. First, fragment interfaces can be disrupted
to reduce interaction affinity (4,22). Second, protein expres-
sion level can be precisely controlled. Third, an additional
layer of inducible control can be added to the regulated sys-
tem (24–26).
While a number of different strategies have been found to
be effective, few detailed studies of parameters affecting ac-
tivity of inducible split proteins have been performed. Here,
we systematically examine the effects of modulating expres-
sion and localization of split protein fragments used to gen-
erate a light activatable Cre DNA recombinase (PA-Cre2.0)
(14). We find that high light activity and low dark back-
ground can be achieved by expressing one half of the split
Cre system at extremely low levels. With increased expres-
sion, background activity of PA-Cre2.0 increases, but re-
mains remarkably low compared to other split Cre recombi-
nase systems. In vivo, PA-Cre2.0 also shows remarkably low
dark activity and robust response to short light inputs. We
establish that the low dark background of PA-Cre2.0 results
from alterations in nuclear-cytosolic shuttling in one of the
split Cre fragments, resulting in a reduced fraction of pro-
tein in the nucleus as overall protein expression increases.
This work suggests a design strategy for achieving tight light
regulation of inducible dimerization systems through tun-
ing nuclear import/export signals to reduce sensitivity to
expression level differences. Extending this approach, we
demonstrate dual control of Cre recombinase activity by
controlling nuclear localization or abundance using a small
molecule and assembly of split fragments using light, pro-
viding more complex control of DNA recombination for a
diverse range of applications.
MATERIALS AND METHODS
Cloning and mutagenesis
Full sequences of constructs used in this manuscript and
primers used for cloning are provided in Supplementary Ta-
ble S1. All CreN constructs contain residues 19–104 of Cre
DNA recombinase, while CreC constructs contain residues
106–343. The constructs mCh-IRES-CRY2(L348F)-CreN
(p688) and mCh-IRES-CIB1-CreC (p645) were described
previously (14). The constructs mCh-IRES-CRY2FL(wt)-
CreN (p221), CRY2FL(+NLS)-mCherry (p950) and the
loxP-STOP-loxP-EGFP reporter are described in Kennedy
et al., (27). The DIO-EGFP reporter (p1053) was gener-
ated by digesting pcDNA3.1+ with EcoRI and EcoRV en-
zymes, then inserting a DIO-EGFP cassette (containing
loxP2272-loxP-invertedEGFP-loxP2272-loxP) from pAAV-
CAG-DIO-EGFP using EcoRI and AfeI sites.
To generate KM10, CIB1-CreC-IRES-CRY2(L348F)-
CreN-IRES-mCh, an intermediate construct (p941, CIB1-
CreC-IRES-CRY2(L348F)-CreN-stop-mCh) was first gen-
erated. To generate this, CIB1-CreC(N1) was digested with
EcoRV and XmaI, and CIB1-CreC-IRES-CRY2(L348F)-
CreN cut at EcoRV-XmaI sites from plasmid GFP-P2A-
CIB1-CreC-IRES-CRY2(L348F)-CreN was inserted (both
plasmids are described in Taslimi et al 2016). Next, the
IRES element from p688 was polymerase chain reaction
(PCR)-amplified (primers 1889f/1890r), and ligated into
p941 cut with XmaI. To generate p985 (CRY2(L348F)-
CreN-IRES-mCh), KM10 was digested with XhoI and re-
ligated to excise the CIB1-CreC-IRES insert. To gener-
ate KM60 (CRY2(L348F)-CreN-IRES-CIB1-CreC-IRES-
mCh), first the CIB1-CreC-IRES insert was cut out from
KM10 using AfeI and SalI and blunt-ended with T4
DNA polymerase. This insert was ligated into a ver-
sion of p985 with the KpnI site mutated, cut with ClaI
(blunt fill in). To generate p1116, CIB1-CreC-IRES-mCh,
KM10 was digested with KpnI then religated, excising
the IRES-CRY2(L348F)-CreN insert. To generate KM10
pA, KM10 was digested with SbfI and AflII (blunt fill)
and ligated to an insert containing IRES-mCherry ampli-
fied with 1677f/687r then digested with SbfI and EcoRV.
To generate the myc-tagged constructs, for p926,
CRY2(L348F)-CreN was PCR-amplified to add a N-
terminal myc tag (primers 1683f/1685r, then 1684f/1685r),
then cloned into p688, replacing CRY2(L348F)-CreN
at SacI and XmaI sites. To generate p1108, the L348F
mutation in CRY2 was mutagenized to wild-type (L348L)
using one-step Phusion mutagenesis protocols from New
England Biolabs. Briefly, oligos containing the 348L
substitution (1145r/2109f) were used to amplify the entire
plasmid using Phusion High-Fidelity DNA Polymerase
(NEB), then the PCR products were treated by T4 Polynu-
cleotide Kinase (NEB) in the presence of ATP at 37◦C for
30 min before self-ligation using T4 Quick Ligase (NEB).
To generate p1133, CRY2(L348F) was PCR ampli-
fied (primers 654f/639r) using p985 as template and di-
gested with NheI and XmaI, then ligated into pmCher-
ryN1 at NheI and XmaI sites. To generate p1089 (mCh-
CRY2(L348F)-CreN), a NheI-XmaI fragment containing
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a modified version of pmCherryC1 (Clontech) in which
the linker between BsrGI and SacI had been replaced
by the sequence agggaggtggaggtgctagc, containing a NheI
site in place of SacI. To generate CW53, CRY2FL was
isolated from p1108 at EcoRI and NotI sites, then lig-
ated into p1089 at the same sites. To generate p1097,
mCh-CRY2(L348F)-CreC, the NotI-XmaI fragment from
CIB1-CreC (containing CreC) was inserted into p1089 di-
gested with NotI and XmaI. To generate p1103 (mCh-
CRY2(L348F)-NLS-CreN), a nuclear localization signals
(NLS) was first added to the C-terminus of CRY2(L348F)
by PCR (primers 1677f/2130r) using p688 as template. This
fragment was ligated into p688 cut with SacI and NotI. To
generate p1105, the CRY2(L348F)-NLS-CreN insert from
p1103 was cut out (EcoRI and XmaI sites) and ligated into
p1097 digested with EcoRI and XmaI. To generate CW184,
the C-terminus of p1089 was modified by PCR to mutate
the putative NES sequence using primers 1290f/2985f then
1290f/2986r. The insert was digested with NotI and XmaI
and ligated into p1089 at the same sites.
To generate p1087 (mCh-CIB1-CreN), a NotI-XmaI
fragment containing CreN was isolated from p688 and
ligated into KM69 at NotI/XmaI sites. To generate
KM69 (mCh-CIB1-CreC(106)-IRES-Cry2(L348F)-CreN),
the mCh-CIB1-CreC(106)-IRES-CRY2(L348F)-CreN in-
sert was isolated from p1071 (SpeI/XmaI sites). The in-
sert was ligated into pmCherryC1 cut with NheI and
XmaI. To generate p1117 (mCh-CIB1-CreC), KM69 was
digested with KpnI and SmaI to remove the IRES-
CRY2(L348F)-CreN fragment, then religated. To generate
KM91 (mCh-IRES-Magnet-PA-Cre), a SnaBI-SacI frag-
ment from p688 (containing the mCherry-IRES insert)
was ligated into Magnet PA-Cre (pcDNA3.1 backbone)
(15). To generate p1115 (CIB1-CreN), a NotI-XmaI frag-
ment containing CreN was ligated into CIB1-CreC(N1) at
NotI/XmaI sites. To generate p1088/KM75 (mCh-IRES-
CRY2(L348F)-CreC), a NotI-XmaI fragment containing
CreC was ligated into p688 at NotI/XmaI sites.
To generate CW40, CRY2(L348F)-CreN was PCR-
amplified from p1089 (primers 2197f/2198r), then di-
gested with KpnI and XhoI for cloning into pcDNA-NES-
PhoCI-mCherry (Campbell lab, Addgene #87690) at KpnI
and XhoI sites. CW59 was generated by PCR amplify-
ing (primers 2264f/1081r) the PhoCl-CRY2(L348F) insert
from CW40. The insert was cut with XhoI and EcoRI and
ligated into p688 previously cut with XhoI and EcoRI.
CW57 was made using primers 2278f/2279r to amplify
a human estrogen receptor ligand binding domain insert,
which was digested with SacI and ligated into CW59 cut
with SacI. To generate CW79, the ecDHFR insert from
pBMNDHFR(DD)-YFP (Wandless lab, Addgene #29325)
was PCR amplified (primers 2561f/2562r) to add ClaI and
SalI ends. The insert was ligated into p688 cut with ClaI and
SalI.
To generate p989, CRY2(L348F)-CreN-P2A-
CIB1-CreC-IRES-mCh, p688 was amplified by PCR
(1689f/1924r, then 1689f/1925r) to add a P2A sequence
at the C-terminus of CRY2(L348F)-CreN. This insert was
digested with EcoRI and KpnI, then ligated into p985
digested with EcoRI and KpnI to generate intermediate
clone p986. In a second step, KM10 was PCR amplified
(primers 1926f/1890r) and the insert digested with KpnI
and XmaI, then ligated into p986 digested with KpnI and
XmaI. To generate AAV constructs, myc-CRY2(L348F)-
CreN or CIB1-CreC were cloned into AAV-CaMKII-GFP
at KpnI and BsrGI sites (where GFP was removed).
Cell culture experiments
HEK293T cells were maintained in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) at 37˚C with 5% CO2. To test split
constructs, 1 g (or indicated amounts) of the loxP-STOP-
loxP-EGFP Cre recombinase reporter (or DIO-EGFP re-
porter, where indicated) and each split fragment were trans-
fected into HEK293T cells on 12-well plates using stan-
dard calcium phosphate transfection methods. Nonspecific
‘stuffer’ DNAwas included in transfections as needed to en-
sure all transfection wells received equal amounts of DNA.
Cells were wrapped in aluminum foil after transfection and
kept in dark for 24 h before blue light treatment (461 nm
delivered from custom-built LED arrays, 7.4–18 mW/cm2).
For extended light treatment, 2 s pulses were delivered every
3 min, or as indicated in figures. Dark samples were kept in
the dark throughout the experiment. Cells were imaged to
quantify reporter fluorescence 24 h after initial onset of light
treatment (48 h after transfection), unless specified other-
wise.
For immunoblotting, cells were harvested 24 h af-
ter transfection, washed in 1× phosphate-buffered saline
(PBS), and lysed in 2× Laemmli sample buffer with boil-
ing. Proteins were separated by electrophoresis on an
sodium dodecyl sulphate-polyacrylamide gelelectrophore-
sis gel and transferred to nitrocellulose membranes, fol-
lowed by probing with primary (anti-Cre recombinase,
Novusbio NB100-56135; anti-tubulin, Li-COR, 926-42213;
anti-myc tag, Sigma M4439) and secondary (goat anti-
rabbit IR-Dye 800CW, LiCOR, 926-32211; goat anti-
mouse IR-Dye 680RD, Li-COR, 926-68070) antibodies. An
Odyssey FC Imager (Li-COR) was used to visualize labeled
immunoblots.
Cre recombinase quantification and statistical comparison
Quantification of Cre DNA recombinase activity was car-
ried out in live cells using a Leica DM IL LED Fluo micro-
scope with L5 ET and TX2 ET filters. Images were taken
with an iPhone7 (Apple) equipped with an iDu microscope
adaptor (iDu Optics) and visualized using ImageJ. The
percent of transfected cells (typically expressing mCherry)
showing EGFP reporter activity was quantified from im-
ages using CellProfiler (https://cellprofiler.org) (28) or man-
ual count, and is indicated in graphs as ‘% Cre recombina-
tion’. Significance for experiments comparing two popula-
tions was determined using a two-tailed unpaired student’s
t-test.
Image analysis
For localization studies, HEK293T cells were seeded onto
coverslips in 12-well plates, transfected with specified plas-
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in 4% paraformaldehyde, washed in 1× PBS, thenmounted
on a glass slide using Fluoromount-G (Southern Biotech).
Cells were imaged on anAndorDragonfly 301 spinning disc
imaging system with Olympus IX73 base and four-line ILE
laser merge module and controller. Images were acquired
using a 60× UPlanSApo 1.35 NA oil objective, and col-
lected on a 1024 × 1024 pixel Andor iXon EM-CCD cam-
era. Data acquisition and analysis were performed with Fu-
sion (Andor) and ImageJ software.
After initial image collection, ImageJ 1.45s was used for
all image analysis. For nuclear:cytoplasmic ratio quantifi-
cation, confocal image Z-stacks were compiled into a max-
imal projection. Total fluorescence in either the nucleus or
cytosol was calculated by manually selecting either the nu-
cleus or cytosolic region of interest and quantifying average
fluorescence and area within these compartments. A sepa-
rate region of the image was used to calculate background,
which was subtracted from the average fluorescence. Aver-
age fluorescence was multiplied by area and calculated for
nuclear vs cytosolic regions, then these were divided to ob-
tain a ratio of nuclear:cytoplasmic protein. To quantify nu-
clear concentration versus total cell fluorescence for Figure
2G, the mean intensity of fluorescence in the nucleus was
background subtracted and reported on the X-axis. The to-
tal cell fluorescence on the Y-axis was defined by multiply-
ing each cell area (manually selected) by the background
subtracted average fluorescence intensity. Values depicted
for each are arbitrary units. Significance for experiments
comparing two populations was determined using a two-
tailed unpaired student’s t-test.
Production of AAVs for in vivo injection
To generate AAVs for injection, we used the AAV-DJ strain.
HEK293T cells were co-transfected with each AAV plas-
mid along with helper plasmids (pDJ and pHelper) using
calcium phosphate transfection. Seventy-two hours post-
transfection cells were harvested, lysed and purified over an
iodixanol gradient column (2 h at 400 000 × g in a Beck-
man Type80Ti rotor). The virus was collected, dialyzed to
remove excess iodixanol and aliquoted and stored at−80◦C
until use.
In vivo studies in mouse
Adult Ai14 mice containing an integrated CAG-loxP-
STOP-loxP-tdTomato cassette at the Gt(ROSA)26Sor lo-
cus were stereotactically injected with a 1:1:1
volume/volume mixture of AAV constructs (AAV-
CaMKII-myc-CRY2(L348F)-CreN, AAV-CaMKII-CIB1-
CreC, and AAV-hSyn-EYFP) into the dentate gyrus.
AAV-CaMKII-myc-CRY2(L348F)-CreN (titer 9.52 × 1011
GC/ml) and AAV-CaMKII-CIB1-CreC (titer 1.53 × 1012
GC/ml) were packaged at the University of Colorado.
AAV-hSyn-EYFP virus was obtained from the University
of North Carolina viral core (https://www.med.unc.edu/
genetherapy/vectorcore/) with a titer of 3.3 × 1012 GC/ml.
For injection, mice were anesthetized with 2% isoflurane,
skin prepped and opened and a small hole was created
in the skull at designated coordinates using a high-speed
drill and burr. A total of 300 nl viral solution was injected
into the dentate gyrus. After injection, a fiber optic was
implanted above the injection site and secured using
meta-bond dental cement. Animals were left to recover for
3 weeks post-surgery. Animals were connected to a patch
cable and a 473 nm laser light source to provide light to
brain tissue. The output at the end of the patch cable was
measured at 15 mW prior to connection to implanted fiber.
Fiber optic implants were made in house with the minimum
acceptable efficiency of 80% (29). Animals were treated
with light (1 s pulse of light through the implanted fiber
optic or no light for control treated animals. One week after
light treatment, mice were transcardially perfused with 4%
paraformaldehyde. The brains were collected, sectioned
and imaged using a Leica DM6 fluorescent microscope.
RESULTS
PA-Cre recombinase activity correlates with CRY2-CreN ex-
pression level
We previously generated a photoactivatable Cre DNA re-
combinase (PA-Cre2.0) in which N- and C-terminal frag-
ments of Cre recombinase were fused to interacting partner
proteins, Arabidopsis thaliana photoreceptor cryptochrome
2 (CRY2) and CIB1, a protein that interacts with light-
stimulated CRY2 (14). In dark, CRY2 and CIB1 have low
affinity and the fused N- and C-terminal fragments of Cre
do not functionally assemble. In light, the fragments are
brought into proximity through light-induced dimerization,
promoting assembly and functional reconstitution of re-
combinase activity. To increase the sensitivity of the sys-
tem to allow high activity in response to brief light input,
we also included a L348F mutation on CRY2 that extends
the photoexcited state, thus allowing extended interaction
of CRY2 with CIB1 after light exposure (14). While PA-
Cre2.0 showed low background and robust light response,
our initial studies did not examine how activity would be al-
tered by differences in expression of split protein fragments
or determine the optimal expression level of the system.One
drawback of many split protein systems is that the affinity
of the N- and C-terminal fragments, required for induced
assembly and reconstitution of activity, can contribute to
background activity in an expression-dependent manner
(11,22). Although our initial choice of split Cre recombi-
nase fragments (CreN, residues 19–104; CreC, residues 106–
343) showedminimal self-assembly when expressed at mod-
erate levels in the cell (14), we had not tested at very high
expression.
As a first step to test and improve the system, we sought
to equalize expression of the CreN and CreC fragments by
generating a bicistronic vector using a P2A cleavable pep-
tide tag. We avoided tagging the CIB1-CreC fragment (i.e.
CIB1-CreC-P2A-CRY2-CreN) as the cistron upstream of
the P2A peptide retains a 18-residue tag at the C-terminus,
and CIB1-CreC was previously found to be intolerant of
an epitope tag at this site (14). Unfortunately, placement
of a P2A tag downstream of CRY2(L348F)-CreN (p989)
substantially reduced recombinase activity (Supplementary
Figure S1). We next tested bicistronic vectors in which the
CIB1-CreC and CRY2(L348F)-CreN fragments were sep-
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A version containing CIB1-CreC upstream, KM10 (CIB1-
CreC-IRES-CRY2(L348F)-CreN), showed good function-
ality in a single construct (Figure 1A andB). Using this con-
struct, we were able to achieve ∼80% recombination rate in
cells treated with just three pulses of light (4s duration each)
spaced 45 min apart (Supplementary Figure S2). However,
we also observed that the CRY2-CreN fragment in this con-
struct was expressed at a much lower level than the CIB1-
CreC fragment (Figure 1C), potentially limiting the system.
Because the cistron downstream of an IRES element of-
ten expresses at lower levels (30), and since CRY2 is of-
ten expressed more poorly than CIB1, we hypothesized that
switching the order of the proteins within the IRES con-
struct (e.g. CRY2(L348F)-CreN-IRES-CIB1-CreC,KM60)
may equalize fragment expression and improve function.
This configuration resulted in higher levels of expressed
CRY2-CreN compared with CIB1-CreC (Figure 1C), but
no functional improvement, showing elevated dark back-
ground with no improvement in light activity (Figure 1B).
Given the significant differences in dark activity resulting
from altering the ratio of CRY2(L348F)-CreN and CIB1-
CreC, we undertook a systematic characterization of the
effect of modulating expression level of each split protein
half. Using separate plasmids to express each fragment,
we tested the CreN or CreC components (CRY2(L348F)-
CreN or CIB1-CreC), positioning each fragment either
upstream or downstream of an IRES element to manip-
ulate expression level. To quantify activity, we included
a mCherry fluorescent reporter in the opposing posi-
tion (i.e. mCherry-IRES-CIB1-CreC) (Figure 1D). Thus,
we tested high-expressing CreC (CIB1-CreC-IRES-mCh,
p1116, +++), low-expressing CreC (mCh-IRES-CIB1-
CreC, p645, +), high-expressing CreN (CRY2(L348F)-
CreN-IRES-mCh, p985, +++) and low-expressing CreN
(mCh-IRES-CRY2(L348F)-CreN, p688, +). Altering the
expression level of CIB1-CreC had no significant effect on
either dark or light activity (Figure 1E). In contrast, increas-
ing CRY2(L348F)-CreN expression resulted in a significant
increase in dark background activity, withminimal effect on
light activity. Combined, these results suggested a correla-
tion between increasedCRY2(L348F)-CreN expression and
dark background.
Since our studies indicated we could maintain high light
activity but reduce dark activity by reducingCRY2(L348F)-
CreN expression, we explored whether we could decrease
expression of this fragment further. A construct (pA)
identified during cloning that lacked much of the polyA
termination signal results in nearly undetectable levels of
CRY2-CreN protein as assayed by immunoblot (Figure
1F), due to the loss of much of the 3′ UTR that acts to stabi-
lize the mRNA. Despite the substantially lower levels of ex-
pressed protein, pA showed similar light-induced activity
asKM10 andminimal dark background activity (1.3%dark
recombination, compared with 5.1% for KM10). These re-
sults suggested that high levels of expression of PA-Cre2.0
were not required for maintaining high activity.
The minimal change to light and dark activity over such
a large range of expression levels was surprising, given that
the split protein fragments are expected to retain moder-
ate affinity for each other in order to reassemble. As ex-
pression increases, the fragments would be expected to in-
teract increasingly, resulting in higher dark background ac-
tivity. Interestingly, when we had originally characterized
the PA-Cre2.0 system, we observed that dark background
was significantly reduced when using L348F CRY2-CreN
compared with wt CRY2-CreN, however we had not com-
pared activity of these constructs at different expression lev-
els. When we reduced the expression of wt CRY2-CreN in
cells, both L348F and wt versions showed similar activity
(Figure 1G). Thus, while PA-Cre with wt CRY2 was highly
dependent on expression level, the L348F variant appeared
to confer activity that was remarkably buffered from expres-
sion level differences.
L348F mutation of PA-Cre2.0 alters nuclear localization to
reduce dark background
To further investigate the low dark background of PA-
Cre2.0, we focused on the L348F mutation. When gener-
ating PA-Cre2.0, we had added this mutation, which ex-
tends the photocycle, to allow reconstitution of the split
fragments for a longer period of time in response to a short
light pulse (14). Given that the CRY2 photocycle pheno-
type would not be expected to manifest in dark, the excep-
tionally low background activity in dark (Figure 1G) was
unexpected, suggesting L348F was also affecting CRY2 in
another way. We first hypothesized that the mutation could
destabilize the CRY2-CreN fragment, but observed no dif-
ference in steady-state protein levels between wt and L348F
versions (Figure 2A).
We next examinedwhether the L348F substitution affects
CRY2 subcellular localization, as both CRY2-CreN and
CIB-CreC fragmentsmust localize to the nucleus to catalyze
DNA recombination. When designing the PA-Cre, to en-
able nuclear localization of each fragment we used versions
of CRY2 and CIB1 that retain endogenous NLS found near
theC-terminus of each protein (27). Indeed, whilemCherry-
taggedwtCRY2was strongly nuclear, L348FCRY2 showed
a reduced proportion of protein in the nucleus (Figure 2B).
These results suggest that the L348F substitution could al-
ter exposure of the CRY2 NLS, or interfere with its interac-
tion with import machinery.
We next examined the localization of the full length
fragment (CRY2-CreN fusion), using mCherry-tagged ver-
sions. With both L348F and wt CRY2, the presence of the
CreN fragment resulted in further reduced nuclear local-
ization (Figure 2C), suggesting adding this domain either
reduced nuclear import or increased nuclear export. Using
NetNES 1.1 prediction software (31), we identified a pre-
dicted nuclear export consensus sequence (NES) ‘LQAR-
GLAV’ at residues 78–85 of Cre recombinase, which re-
sides in the CreN fragment. We hypothesized that this mo-
tif and the L348F mutation act additively to restrict lev-
els of CRY2(L348F)-CreN in the nucleus, resulting in the
low background activity observed. Indeed, mutating the
critical ‘LxV’ of the predicted NES to ‘LQARGAAA,’ to
yield CRY2(L348F)-CreN(NES) resulted in significantly
increased nuclear localization (Figure 2C). When we added
a strong SV40NLS to CRY2(L348F)-CreN (Figure 2C), we
also observed an increase in nuclear localization, along with
a corresponding increase in dark background activity (Fig-
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Figure 1. Alteration of expression level of CRY2-CreN and CIB1-CreC fragments causes changes in dark background, with minimal effects on light-
induced activity. (A) Schematic showing combined constructs used in (B) and (C). (B) Quantification of Cre recombinase activity in HEK293T cells. Cells
expressing CRY2(L348F)-CreN in front of an IRES element (KM60) show higher dark background compared with KM10. Cells were transfected with
indicated plasmids and a loxP-STOP-loxP-EGFP reporter, then kept in dark and harvested at 48 h. Light-treated samples were exposed to a 4 s pulse of
light at 24 h. Graph shows average and error (s.d., n = 4–6 independent experiments). (C) Immunoblot comparing expression of Cre fragments in KM10
versus KM60 (anti-Cre antibody, top panel; anti-tubulin, bottom panel). (D) Immunoblots of dual plasmid system. HEK293 cells were transfected with
indicated constructs and immunoblotted with an anti-Cre antibody (top). Bottom panel shows anti-tubulin loading control. Control lane consisted of
non-transfected cells. (E) Quantification of Cre recombinase activity in HEK293T cells transfected with indicated constructs and light-treated as in (B).
Protein expression level as determined in (D) is indicated below the graph, with ‘+’ (low expression) or ‘+++’ (high expression). Graph shows average
and error (s.d., n = 3–5 independent experiments). (ns, not significant; *, P < .05, student’s t-test). (F) Comparison of expression level and activity of
HEK293T cells expressing a combined PA-Cre2.0 construct (KM10), or an identical version (pA) with a mutant polyadenylation signal. Expression of
the Cre fragments is greatly reduced in thepA version. Dark background activity is significantly reduced (*, P< .05), but no significant difference in light-
stimulated activity is observed. Graph shows average and error (s.d., n = 3–6 independent experiments). (G) Quantification of Cre recombinase activity
with different amounts of wt or L348F CRY2-CreN. All samples contained 1 g EGFP Cre reporter and 1 g p645 (CIB1-CreC) and were quantified 48
h post-transfection. Light samples received a 4 h light exposure at 24 h (2 s pulse every 1 min, 461 nm). Samples labeled ‘high’ were transfected with 1 g
of L348F or wt CRY2-CreN; ‘low’ samples contained 50 ng. Graph shows average and range of two independent experiments.
the constructs, to generate mCherry-CRY2(L348F)-CreC
(p1097) and mCherry-CIB1-CreN (p1087), resulted in con-
structs with predominantly nuclear localization (Figure
2E), but also higher dark background compared with the
original system (Figure 2F).
To more precisely explore the differences between wt or
L348F versions of CRY2-CreN, we imaged the mCherry-
tagged fragments and quantified the concentration of pro-
tein in the nucleus as total protein expression increased (Fig-
ure 2G). With both wt and L348F CRY2, the concentra-
tion of protein in the nucleus increased as total cell fluo-
rescence increased. At all expression levels, the concentra-
tion of L348FCRY2-CreN in the nucleus was lower than wt
CRY2-CreN. These results support that the reduced dark
background of L348F is due to reduced nuclear localiza-
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Figure 2. CRY2 L348F mutant shows reduced nuclear localization. (A) Reduced dark activity of CRY2(L348F)-CreN is not due to reduced overall ex-
pression. Shown is an immunoblot of cells (anti-myc antibody) expressing myc-tagged versions of wild-type or L348F CRY2-CreN. Loading control,
Ponceau S total protein reference band. (B) Localization of mCherry-fused versions of CRY2 (wild-type) or CRY2 L348F. The L348F mutation reduces
the percent of expressed protein localized to the nucleus. Graph at right shows quantification of the ratio of nuclear:cytosolic protein (average and error,
s.e.m, n = 7 cells; *, P < .05, student’s t-test). Scale bars, 10 m. (C) mCherry-fused versions of L348F CRY2-CreN show even further reduced nuclear
localization, compared to wt. Mutation of a putative ‘NES’ in CreN (CreN NES) or addition of an extra NLS (far right, CRY2-L348F-NLS) restores
nuclear localization. Graph at right shows quantification of nuclear:cytosolic protein (average and error, s.e.m., n = 7 cells (10 cells for NES); *, P <
.05, student’s t-test). Scale bars, 10 m. (D) Quantification of Cre recombinase activity. Addition of an extra NLS (to generate CRY2(L348F)-NLS-CreN)
results in enhanced dark activity, with minimal effects on light activity. Graph represents average and range from two independent experiments. (E) Local-
ization of switched CreN and CreC versions. While CRY2(L348F) combined with CreN shows reduced nuclear localization, switched CRY2(L348F)-CreC
shows strong nuclear localization. The CIB1 construct shows strong nuclear localization with either CreC or CreN. Scale bars, 10 m. (F) Quantification
of Cre recombinase activity in cells expressing CRY2(L348F)-CreN/CIB1-CreC (‘original’) or CRY2(L348F)-CreC/CIB1-CreN (‘switched’) versions of
PA-Cre. Both mCherry-fused and non-fused versions of CIB1-CreN were assayed and results combined. Data represents average and error (s.d., n = 4–
6 independent experiments; P < .05, student’s t-test). (G) Quantification of nuclear fluorescence relative to total cell fluorescence. HEK293T cells were
transfected with increasing amounts of wt or L348F mCh-CRY2-CreN. The concentration of mCherry fluorescent signal in the nucleus, relative to total
protein abundance, was quantified. Each dot represents an individual cell, arbitrary units. Red triangles, wt; blue circles, L348F. At all concentrations, wt
expressing cells show higher nuclear signal compared with L348F. (H) Model of CRY2(L348F)-CreN nuclear trafficking. The CreN fragment contains a
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pression levels increase overall. In Figure 2H we propose a
model of PA-Cre2.0 nuclear trafficking. The effect of com-
bining a L348F CRY2 protein with reduced nuclear occu-
pancy with a CreN fragment that promotes nuclear export
leads to a CreN version that is predominantly cytosolic, but
that undergoes nuclear shuttling. Thus, at any given time,
some fraction of the protein would be available in the nu-
cleus to induce recombination with light. Because the ma-
jority of protein is buffered in the cytosol, we speculate that
such a design is less sensitive to expression level differences,
resulting in universally low dark background activity.
Comparison of PA-Cre2.0 with Magnet-actuated PA-Cre
We hypothesized that the unique design of PA-Cre2.0 may
provide an advantage over other split systems that are
strongly nuclear localized, such as the Magnet PA-Cre sys-
tem (15), which has a strong SV40NLS attached to eachCre
half. Mag PA-Cre uses a similar split fragment approach,
but uses nMag/pMag (‘Magnet’) photodimerizers and a
different Cre split site (15). To directly compare these two
systems, we placedMag PA-Cre downstream of a mCherry-
IRES element (i.e. mCh-IRES-MagPA-Cre, KM91) and
used a EGFP DIO (Double-floxed Inverse Open reading
frame) Cre reporter (32), allowing quantification of Cre ac-
tivity by recording the number of mCherry-expressing cells
with EGFP expression.We tested the responses of both sys-
tems in side-by-side experiments in dark, or after exposure
to 4 s or 4 h blue light (Figure 3).
Because different dimerizer-induced split protein systems
have different optimal expression levels, it is essential to ex-
plore a range of expression levels when comparing differ-
ent systems. Previous studies with Mag PA-Cre indicated
that the optimal dynamic range of the system required sub-
stantially lower expression, as these prior experiments used
much lower amounts of transfected Mag PA-Cre DNA
(typically, a 1:9 ratio of Mag PA-Cre to Cre reporter was
used) (15). We tested equivalent conditions as previously
used, using a 1:9 ratio of Mag PA-Cre relative to the Cre
reporter and transfected similar amounts of DNA (50 ng
MagPA-Cre, 450 ng DIO reporter) (Figure 3A). In turn,
we tested expression of CRY2/CIB1 PA-Cre2.0 under sim-
ilar expression conditions (50 ng PA-Cre2.0 and 450 ng re-
porter). We compared these results at low expression levels
with results at higher expression using 20-fold more DNA
(1 g PA-Cre and 1 g reporter). At the higher expres-
sion level, the Mag PA-Cre showed high background, but
this was dramatically reduced at the lower (optimized) ex-
pression level. The CRY2/CIB-actuated PA-Cre2.0 system
performed equally well at both high (1:1 ratio Cre:reporter,
1g PA-Cre2.0) and low (1:9 ratio, 50 ng PA-Cre2.0) lev-
els. At the low (1:9) expression level, Mag PA-Cre showed
higher dark background and reduced light-induced stimu-
lation compared with PA-Cre2.0, resulting in lower over-
all dynamic range (ratio of activity in light/dark was 6.8
for Mag PA-Cre, compared with 154.5 for CRY/CIB PA-
Cre2.0). When compared using expression levels optimized
for each system (1:1 ratio for PA-Cre2.0; 1:9 ratio for Mag
PA-Cre), PA-Cre2.0 also showed enhanced dynamic range
and higher levels of recombination in response to a short
4 s light pulse (Figure 3B). We also note that these results
showing high activity of CRY2/CIB1 PA-Cre2.0 with the
DIO reporter indicate this system is able to catalyze recom-
bination events at non-canonical loxP sites, which has not
been previously demonstrated.
In vivo validation of PA-Cre2.0
The consistent activity afforded by PA-Cre2.0 in cell cul-
ture, with minimal background even at higher expression
levels, suggested the system would be well-suited for use
in vivo. We thus tested the system with viral delivery in
vivo in mouse brain, expressing each Cre half in an AAV
vector and using a CaMKII promoter to impart neuronal
expression (pAAV-CaMKII-myc-CRY2(L348F)-CreN and
pAAV-CaMKII-CIB1-CreC). To visualize induced recom-
binase activity in mouse, we used Ai14 Cre reporter mice,
which contain an integrated loxP-flanked STOP cassette
preventing transcription of a CAG promoter-driven td-
Tomato reporter (33). These mice express tdTomato fluo-
rescent protein upon Cre mediated-recombination.
Ai14 mice were stereotactically injected in the dentate
gyrus with virus comprising each of the two Cre halves, as
well as a hSyn-EYFP virus to mark the site of injection, as
shown in Figure 4A. Mice were implanted with an optical
fiber targeted directly above the injection site (Figure 4B).
Three weeks after injection and implantation, mice were ei-
ther exposed to a 1 s pulse of blue (473 nm) light via a
patch cable connected to the implanted fiber, or no light
for control animals. Minimal expression of tdTomato was
observed in brains from control mice not exposed to the
blue light pulse (Figure 4C, top row). Brains from animals
treated with a 1 s light pulse showed tdTomato expression
in CaMKII positive neurons directly below the implanted
fiber (Figure 4C, bottom row). These results indicate low
background recombination can be achieved in vivo using vi-
rally delivered components. In addition, Cre recombination
can be effectively triggered in vivo as well as in vitro (cell cul-
ture) by a very brief light input (a single 1 s light pulse).
Manipulation of split Cre fragment nuclear localization for
tunable activity control
Our results indicated that expressing bothCre halves at high
levels in the nucleus is a major contributor to dark back-
ground activity, presumably due to the affinity of the two
split Cre fragments. We hypothesized that we could achieve
tighter control of activity by combining two inducible sys-
tems, wherein abundance or nuclear accumulation of the
CRY2-CreN fragment is manipulated by a first inducible
system, followed by light-induced fragment reconstitution.
In theory, by restricting the amount of CRY2-CreN frag-
ment available for recombination until an inducible signal,
we could achieve very tightly controlled recombination ac-
tivity with very low background. Such an approach has pre-
viously been used to improve dynamic range of split and
allosterically-controlled CRISPR switches (24,34).
To first test this concept, we fused the CRY2(L348F)-
CreN fragment to a destabilized Escherichia coli DHFR
that is unstable unless bound to the small molecule
trimethoprim (TMP) (35). Previous studies demonstrated
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Figure 3. Functional comparison of CRY2/CIB1 PA-Cre2.0 with Mag PA-Cre. (A) Comparison of PA-Cre2.0 and Mag PA-Cre activity at different
expression levels. HEK293T cells were transfected with either 1 g of each indicated Cre system (KM69 or KM91) and 1 g DIO-EGFP reporter (1:1
ratio), or with 50 ng each Cre system and 450 ng reporter (1:9 ratio). Samples were treated with dark or 4 h light at 24 h, before quantifying at 48 h. Graph
indicates average and range of two independent experiments. (B) Comparison of PA-Cre2.0 andMag PA-Cre responses to a 4 s light pulse. HEK293T cells
were transfected with 1 g of PA-Cre2.0 (KM69) and 1 g DIO-EGFP or loxP-STOP-loxP-EGFP reporter (1:1), or 50 ng ofMag PA-Cre (KM91) and 450












































Figure 4. In vivo validation of PA-Cre2.0. (A) AAVs (hSyn-EYFP,CaMKII-mycCRY2(L348F)-CreN andCaMKII-CIB1-CreC) weremixed at a 1:1:1 ratio
and injected into the dentate gyrus of Ai14 reporter mice. (B) Mice were implanted with an optical fiber (dashed outline in Figure 2C) over hippocampus.
(C) Representative images from control animals (no light pulse, top row) or animals exposed to a 1 s pulse of blue light (473 nm) (‘Light’, bottom row).
EYFP (green) marks virally infected neurons, with DAPI nuclear staining highlighted in blue. Minimal tdTomato expression (red) was observed in control
animals (n= 3) that did not receive light, while light-treated animals (n= 3) showed Cre-dependent tdTomato expression in CaMKII positive cells in brain.
Scale bar, 400 m.
combinase in mouse brain, with induced Cre function af-
ter delivery of TMP, a relatively inexpensive compound that
passes the blood-brain barrier (36).We generated ecDHFR-
CRY2(L348F)-CreN and tested activity of the recombinase
with or without prior addition of TMP (Figure 5A and B).
In the absence of TMP, we observed minimal activity in
dark or light (0.2% of cells showing recombination in dark,
2.3% in light). With 10 M TMP, we observed low back-
ground in dark (0.6%) but 29% of cells underwent recombi-
nation after a 30 min light treatment (delivered 20 min to 2
h after TMP addition).
As a second approach, we tested a method to trap
CRY2(L348F)-CreN in the cytosol and allow release with
light, by tethering to a NES-PhoCl construct. PhoCl is an
engineered protein derived from a mMaple fluorescent re-
porter that undergoes self-cleavage with 400 nm light appli-
cation (37). We reasoned that fusion to NES-PhoCl could
trap the CRY2-CreN half in the cytosol in dark, but allow
release with UV light. However, we were unable to observe
any improvement in dynamic range of the system using this
approach (Supplementary Figure S3). Because 400 nm light
can stimulate CRY2-CRY2 self-association, we speculate
that the PhoCl light treatment could affect CRY2 nuclear
entry, but did not investigate this further.
In a similar approach to trap one of the fragments in
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Figure 5. Light and chemical regulation of Cre recombinase activity. (A) Schematic of TMP-regulated PA-Cre, in which destabilized Escherichia coli
DHFR is fused to the CRY2(L348F)-CreN fragment. (B) HEK293T cells were transfected with the constructs indicated in (A) (CW79, 1 g; p645, CIB1-
CreC, 1 g), along with a loxP-STOP-loxP-EGFP reporter (1 g). Twenty-four hours after transfection, TMP (10 M) was added to indicated samples.
After 30–120 min, samples were maintained in dark or exposed to light (461 nm pulse, 2 s every 2 min for 30 min) then quantified at 48 h. Graph represents
average and error (s.d., n= 3 independent experiments). (C) Schematic of estradiol-and-light-regulated Cre recombinase, containing an ER-LBD fused to
CRY2(L348F)-CreN. (D) HEK293T cells were transfected with the constructs indicated in (C) (CW57, 1 g; p645, CIB1-CreC, 1 g), and a loxP-STOP-
loxP-EGFP reporter (1 g). Twenty-four hours after transfection, 17--estradiol (400 nM) was added to indicated samples, then samples were kept in dark
or exposed to 4 h light (461 nm pulse, 2 s every 3 min), then quantified at 48 h. Control samples labeled ‘No LBD’ contained p688, p645 and the reporter.
Graph represents average and range of two independent experiments.
CreN fragment to a human estrogen receptor alpha ligand-
binding domain (ER-LBD). Steroid hormone LBDs such
as ER-LBD are effectively trapped in the cytosol in the
absence of ligand due to interaction with Hsp90. Addi-
tion of hormone releases the protein from Hsp90 and al-
lows nuclear import (38). The ER-fused construct, ER-
CRY2(L348F)-CreN, showed minimal activity in light or
dark in the absence of 17-ß-estradiol, with 8-fold re-
duced dark background compared with CRY2(L348F)-
CreN (Figure 5C and D). In samples exposed to estradiol
butmaintained in dark, backgroundwas also reduced (2.9%
recombination with ER fusion, compared with 4.2% with-
out ER fusion). In turn, the addition of estradiol plus light
led to high activity, comparable to activity obtainedwithout
the ER fusion. These results indicate that use of the ER-
LBD-fused CRY2-CreN fragment can further reduce dark
background, while enabling high levels of induced recom-
bination with light plus hormone. Such a system (replacing
ER LBD with a tamoxifen-responsive variant) (39) may be
useful for in vivo studies, as it reduces potential dark back-
ground during long term expression and removes the re-
quirement for samples to be maintained in dark at all times
prior to adding the ligand.
DISCUSSION
In this work, we systematically explored methods for
achieving tight control of activity of a split protein, pho-
toactivatable Cre DNA recombinase, that would be effec-
tive over a wide range of protein expression levels. Pho-
toactivatable Cre recombinase (PA-Cre2.0) consists of split
Cre protein fragments that are brought in proximity by a
light-dependent interaction between the plant photorecep-
tor CRY2 (containing a L348F mutation), and its binding
partner CIB1. We observed that activity of PA-Cre2.0 was
relatively insensitive to differences, in particular, in expres-
sion of the CRY2(L348F)-CreN fragment. We found that
insensitivity was due to reduced nuclear localization of this
fragment caused by a combination of two factors: weak-
ening of the endogenous CRY2 nuclear localization by the
L348F mutation, and a cryptic NES identified in the CreN
fragment. With this combination, the protein is expected to
shuttle into and out of the nucleus, but is predominantly re-
tained in the cytosol, resulting in steady but lower nuclear
levels than observed with the higher background wild-type
protein.
Our study provides new results showing that only very
low levels of protein and light are needed to achieve high
levels of Cre recombinase activity. We demonstrated that
high light induction (up to ∼80% of cells showing recom-
bination) could be achieved using just three 4 s light pulses,
spaced 45 min apart. The system is also highly sensitive,
even when the fragments are expressed at very low lev-
els. A RNA-destabilized version of PA-Cre2.0 (pA) that
produced protein levels that were nearly undetectable by
immunoblot nevertheless maintained high induced activ-
ity and low background in functional activity tests. Our re-
sults also unequivocally demonstrate that Cre recombinase
split at residue 105 is fully competent to catalyze recombi-
nation events at non-canonical loxP sites such as used in
DIO/FLEx recombinase reporters. A previous study (15)
had proposed that photoactivatable Cre recombinase split
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tion at non-canonical loxP sites, however we believe the dis-
crepancy was due to utilization of the prior-characterized
system at non-optimal expression levels. As we demon-
strate here, Cre recombinase split at residue 105 functioned
equally well with a DIO reporter using alternate loxP sites
(loxP2272), as with a loxP-specific recombinase reporter.
We followed up our in vitro characterization of PA-Cre2.0
with functional testing in vivo in rodent brain. In these ex-
periments, due to packaging size limits for AAV vectors, we
packaged each fragment into a separate AAV, then com-
bined the two for injection in the brain. Our in vivo re-
sults, which used a completely different approach to deliver
protein (viral transduction) and tested the system in a dif-
ferent cell type and organism, showed very similar perfor-
mance as compared with the cell culture studies, with mini-
mal background in dark, high induced activity, and sensitive
response to a single 1 s light pulse. As the CRY2/CIB1 inter-
action can be stimulated by two-photon excitation (14,27),
we expect PA-Cre2.0 can also be stimulated with multipho-
ton activation, although did not test this specifically.
As the combination of light and nuclear localization are
important for activity, we extended our findings to develop
two additional photoactivatable Cre approaches that add
chemical regulation increasing the selectivity of the sys-
tem. A number of recent studies have incorporated dual
control mechanisms for achieving tighter inducible regula-
tion, compared with single-chemical or light-regulated sys-
tems (24–26,34). For example, an approach combining two
inducible systems was previously demonstrated to reduce
background of a nuclear import photoswitch (26). Here,
we generated a light-and-estrogen regulated recombinase in
which estrogen regulates nuclear entry of the CRY2-CreN
fragment, while light is required for split fragment reconsti-
tution. Likewise, a version of CRY2-CreN fused to a desta-
bilization domain showed low background and high activ-
ity in the presence of light and a stabilizing drug. We expect
these new versions of PA-Cre2.0 to offer further versatility
for use in vivo. While this work focuses on ways to induce
Cre recombinase activity, with additional engineering these
approaches can also be used to generate versatile sensors
based on Cre recombinase activity. For example, by fusing
a NLS-deleted version of the CRY2-CreN fragment to a
protein that conditionally localizes to the nucleus, cells that
show nuclear import of this protein within a specific time
defined by light can be permanently marked and tracked.
An important implication of our study is that for opti-
mal inducible regulation of a split nuclear enzyme, a strong
NLS is not always desired, and may in fact be detrimental.
Indeed, when we added a SV40 NLS to the CRY2-CreN
fragment, we obtained high background. Likewise, when
we tested an alternate Magnet-actuated PA-Cre system (15)
that contains a strong NLS on each fragment, we observed
high background activity as expression increased. We hy-
pothesize that manipulating the balance of nuclear import
and export could be useful not only with Cre recombinase,
but also for achieving tight regulation of other split pro-
tein systems that are specifically localized to the nucleus
or cytosol. In this manner, proteins can be engineered that
inhabit both compartments, but are tuned to be predomi-
nantly localized in one or the other compartment as needed,
resulting in consistent function despite expression level vari-
ation in different cell types and organisms.
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